标题
Epigenetic agents in combined anticancer therapy
作者
关键词
-
出版物
Future Medicinal Chemistry
Volume 10, Issue 9, Pages 1113-1130
出版商
Future Science, LTD
发表日期
2018-04-20
DOI
10.4155/fmc-2017-0203
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting triple negative breast cancer with histone deacetylase inhibitors
- (2017) Palma Fedele et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat
- (2017) Kenneth Kin-Wah To et al. LUNG CANCER
- Lung cancer epigenetics: From knowledge to applications
- (2017) Michaël Duruisseaux et al. SEMINARS IN CANCER BIOLOGY
- DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia
- (2017) Christian Flotho et al. SEMINARS IN CANCER BIOLOGY
- Multimodality Treatment of Gastric Lymphoma
- (2017) Naruhiko Ikoma et al. SURGICAL CLINICS OF NORTH AMERICA
- Adjuvant Therapy for Melanoma
- (2017) Aya Agha et al. Current Oncology Reports
- Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
- (2017) Roberta Mazzone et al. Clinical Epigenetics
- Oxytetracycline induces DNA damage and epigenetic changes: a possible risk for human and animal health?
- (2017) Adriana Gallo et al. PeerJ
- Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis
- (2017) Li Ma et al. Frontiers of Medicine
- Synergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K/Akt/mTOR and NF-κB signal pathways in thyroid carcinoma cells
- (2016) Si Hyoung Kim et al. BIOMEDICINE & PHARMACOTHERAPY
- Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
- (2016) Chun-Hao Pan et al. BMC CANCER
- Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells
- (2016) Taichi Takashina et al. CANCER SCIENCE
- Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors
- (2016) D. Diedrich et al. CHEMICAL COMMUNICATIONS
- Differential expression and response to arsenic stress of MRPs and ASAN1 determine sensitivity of classical multidrug-resistant leukemia cells to arsenic trioxide
- (2016) Jing Chen et al. LEUKEMIA RESEARCH
- Analysis of Ferrous on Ten-Eleven Translocation Activity and Epigenetic Modifications of Early Mouse Embryos by Fluorescence Microscopy
- (2016) Ming-Hui Zhao et al. MICROSCOPY AND MICROANALYSIS
- Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor – Synergistic action of quercetin and curcumin
- (2016) Vikas Sharma et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
- (2016) Antonio Marchini et al. Viruses-Basel
- Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathway
- (2016) Na-Na Tao et al. Oncotarget
- Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells
- (2016) Shrikant Pradhan et al. Oncotarget
- Histone acetyltransferases: challenges in targeting bi-substrate enzymes
- (2016) Hannah Wapenaar et al. Clinical Epigenetics
- Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non–Small Cell Lung Carcinoma Cells
- (2016) Jair Bar et al. NEOPLASIA
- Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma
- (2016) Mohamed Ashraf Khalil et al. PLoS One
- Predicting chemotherapeutic drug combinations through gene network profiling
- (2016) Thi Thuy Trang Nguyen et al. Scientific Reports
- Targeting the invasive phenotype of cisplatin-resistant Non-Small Cell Lung Cancer cells by a novel histone deacetylase inhibitor
- (2015) Valentina Zuco et al. BIOCHEMICAL PHARMACOLOGY
- Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway
- (2015) Chih-Ming Ho et al. BMC CANCER
- Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer
- (2015) Seok-Mo Kim et al. BMC CANCER
- Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer
- (2015) Rishabh Kala et al. BMC CANCER
- Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth
- (2015) S Adi Harel et al. CELL DEATH AND DIFFERENTIATION
- Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine
- (2015) Theresa D Ahrens et al. Epigenetics
- Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines
- (2015) MD. ALI ASGAR et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells
- (2015) Sujan Badal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents
- (2015) Kai Xue et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma
- (2015) Hiroshi Nakashima et al. JOURNAL OF CLINICAL INVESTIGATION
- DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells
- (2015) Shunsuke Noguchi et al. MELANOMA RESEARCH
- The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells
- (2015) Lotte M.E. Berghauser Pont et al. PLoS One
- Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line
- (2015) Federica Baldan et al. International Journal of Endocrinology
- Effects of histone deacetylase inhibitor trichostatin A combined with cisplatin on apoptosis of A549 cell line
- (2015) Xuan Zhang et al. Thoracic Cancer
- Vorinostat enhances chemosensitivity to arsenic trioxide in K562 cell line
- (2015) Nainong Li et al. PeerJ
- Synergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancer
- (2015) XIUJUN HAN et al. Molecular Medicine Reports
- New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells
- (2015) Fabien Gueugnon et al. Oncotarget
- Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer
- (2015) Frank P. Vendetti et al. Oncotarget
- Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirus
- (2015) Holger Schipper et al. Oncotarget
- Arsenic Trioxide Inhibits DNA Methyltransferase and Restores TMS1 Gene Expression in K562 Cells
- (2014) Hongli Li et al. ACTA HAEMATOLOGICA
- Reversal of Resistance towards Cisplatin by Curcumin in Cervical Cancer Cells
- (2014) Madhumita Roy et al. Asian Pacific Journal of Cancer Prevention
- Development and classes of epigenetic drugs for cancer
- (2014) Dashyant Dhanak et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells
- (2014) Tiffany A. Katz et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic perspectives of epigenetically active nutrients
- (2014) M Remely et al. BRITISH JOURNAL OF PHARMACOLOGY
- Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2ʹ-deoxycytidine-triggered invasiveness
- (2014) David Cheishvili et al. CARCINOGENESIS
- The deep end of the metabolite pool: influences on epigenetic regulatory mechanisms in cancer
- (2014) Kendra K. Nordgren et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- SGI-110 and entinostat therapy reduces lung tumor burden and reprograms the epigenome
- (2014) Carmen S. Tellez et al. INTERNATIONAL JOURNAL OF CANCER
- Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells
- (2014) Sanjay Kumar et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inhibitors of Histone Deacetylases Enhance Neurotoxicity of DNA Damage
- (2014) A. Vashishta et al. NEUROMOLECULAR MEDICINE
- Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia
- (2014) Sarah M. Leonard et al. PLoS One
- Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance
- (2014) Ercan Cacan et al. PLoS One
- DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells
- (2014) Sylwia Flis et al. PLoS One
- Treatment of Nasopharyngeal Carcinoma Cells with the Histone-Deacetylase Inhibitor Abexinostat: Cooperative Effects with Cis-platin and Radiotherapy on Patient-Derived Xenografts
- (2014) Mélanie Gressette et al. PLoS One
- Histone Deacetylase Inhibitors Sensitize Lung Cancer Cells to Hyperthermia: Involvement of Ku70/SirT-1 in Thermo-Protection
- (2014) Mohamed K. Hassan et al. PLoS One
- The KDM2B- Let-7b -EZH2 Axis in Myelodysplastic Syndromes as a Target for Combined Epigenetic Therapy
- (2014) Ekapun Karoopongse et al. PLoS One
- Different Effects of Epigenetic Modifiers on the Cytotoxicity Induced by 5-Fluorouracil, Irinotecan or Oxaliplatin in Colon Cancer Cells
- (2013) Mika Ikehata et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies
- (2013) Wei-Jan Huang et al. CANCER LETTERS
- Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas
- (2013) Junwei Li et al. EMBO Molecular Medicine
- Effects of cisplatin and panobinostat on human mesothelial (Met-5A) and malignant pleural mesothelioma (MSTO-211H) cells
- (2013) K.E. Gultekin et al. GENETICS AND MOLECULAR RESEARCH
- Statins inhibit tumor progressionviaan enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer
- (2013) S. Ishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF- B-Dependent Autophagy
- (2013) L. Shulak et al. JOURNAL OF VIROLOGY
- Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8
- (2013) Xiaobo Hu et al. LEUKEMIA RESEARCH
- TET1 plays an essential oncogenic role in MLL-rearranged leukemia
- (2013) H. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase inhibitors and pancreatic cancer: Are there any promising clinical trials?
- (2013) Ioannis Koutsounas WORLD JOURNAL OF GASTROENTEROLOGY
- Inhibitory effect of valproic acid on bladder cancer in combination with chemotherapeutic agents in vitro and in vivo
- (2013) DEGUI WANG et al. Oncology Letters
- Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells
- (2012) Y Watanabe et al. CANCER GENE THERAPY
- Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives
- (2012) Federico Andreoli et al. CURRENT PHARMACEUTICAL DESIGN
- Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma
- (2012) Soo Jin Bae et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells
- (2012) Burcak Karaca et al. MOLECULAR BIOLOGY REPORTS
- Mining Gene Expression Signature for the Detection of Pre-Malignant Melanocytes and Early Melanomas with Risk for Metastasis
- (2012) Camila Ferreira de Souza et al. PLoS One
- Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation
- (2012) María F. Montenegro et al. PLoS One
- Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer
- (2011) B. Stefanska et al. CANCER RESEARCH
- Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL
- (2011) Vitaliy O. Kaminskyy et al. CARCINOGENESIS
- CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors
- (2011) S Negrotto et al. LEUKEMIA
- Simultaneous inhibition of DNA methyltransferase and histone deacetylase induces p53-independent apoptosis via down-regulation of Mcl-1 in acute myelogenous leukemia cells
- (2011) Chie Nishioka et al. LEUKEMIA RESEARCH
- Genomic DNA Hypomethylation by Histone Deacetylase Inhibition Implicates DNMT1 Nuclear Dynamics
- (2011) M. K. Arzenani et al. MOLECULAR AND CELLULAR BIOLOGY
- Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
- (2010) T. Bianco-Miotto et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Hs.137007 is a novel epigenetic marker hypermethylated and up-regulated in breast cancer
- (2010) Kim INTERNATIONAL JOURNAL OF ONCOLOGY
- Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers
- (2010) Jason A. Dubovsky et al. LEUKEMIA RESEARCH
- Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
- (2009) N Steele et al. BRITISH JOURNAL OF CANCER
- Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205
- (2009) Sylwia Flis et al. Cancer Cell International
- Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells
- (2009) Maiko Suzuki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
- (2009) D. D. Vo et al. CANCER RESEARCH
- Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma
- (2009) F. Vandermeers et al. CLINICAL CANCER RESEARCH
- MS275 enhances cytotoxicity induced by 5-fluorouracil in the colorectal cancer cells
- (2009) Sylwia Flis et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Combined inhibition of Dnmt and mTOR signaling inhibits formation and growth of colorectal cancer
- (2009) Yan-Jie Zhang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- p53-Inducible Ribonucleotide Reductase (p53R2/RRM2B) Is a DNA Hypomethylation-Independent Decitabine Gene Target That Correlates with Clinical Response in Myelodysplastic Syndrome/Acute Myelogenous Leukemia
- (2008) P. A. Link et al. CANCER RESEARCH
- Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs
- (2008) Kei-ichi Ozaki et al. CANCER SCIENCE
- Promoter hypomethylation regulates CD133 expression in human gliomas
- (2008) Kouichi Tabu et al. CELL RESEARCH
- Targeted Therapies to Improve Tumor Immunotherapy
- (2008) J. Begley et al. CLINICAL CANCER RESEARCH
- Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells
- (2008) Q. Zhou et al. MOLECULAR CANCER RESEARCH
- Histone Deacetylase Inhibitors Augment Antitumor Efficacy of Herpes-based Oncolytic Viruses
- (2008) Akihiro Otsuki et al. MOLECULAR THERAPY
- Mammalian target of rapamycin pathway inhibition enhances the effects of 5-aza-dC on suppressing cell proliferation in human gastric cancer cell lines
- (2008) DanFeng Sun et al. Science in China. Series C, Life sciences / Chinese Academy of Sciences
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More